AAAAAA

   
Results: 1-7 |
Results: 7
An open letter to the Committee on the Nobel Prize in Medicine
Authors: Abbruzzese, G Agid, Y Albanese, A Alf, C Allen, R Amar, K de Andrade, LA Ang, LC Angelini, C Archer, RL Arunodaya, GR Baltzan, M Baral, K Barnett, H Bergamasco, B Berger, M Bernard, J Bharucha, NE Bhatia, K Blary, N Black, S Bodis-Wollner, I Boyson, SJ Bral-Kulaksizoglu, I Brooks, DJ Brown, JD Burke, RE Calne, DOC Calne, SM Cardoso, F Cardozo-Pelaez, F Chang, YJ Chen, CC Chen, RS Chen, R Chowdhury, A Christie, S Chu, CC Chu, NS Clarida, L Collette, EM Comella, C Conneally, PM Crossman, AR Csanda, E Dalmau, J Dalvi, A De Feijter, A Deecke, L Desai, H De Ybenes, J Dihenia, B Direnfeld, L Dodel, R Donat, J Doudet, D Duane, DD Duff, J Duvoisin, R Eggert, K Elble, RJ Elmer, LW Emre, M Fariello, R Fernendy, HH Findley, LJ Fink, S Freissmuth, M Friedman, JH de la Fuente-Fernandez, R Furtado, S Furukawa, Y Galvez-Jimenez, N Gauthier, S Gawel, MJ Gilman, S Gladstone, RM Goetz, CG Gomori, A Gopinathan, G Gordin, A Gorell, JM Greenamyre, JT Grimes, DA Gurvit, H Guttman, M Guzman, DA Hachinski, V Hanagasi, H Hardy, J Harik, SJ Hassan, MN Hattori, N Hauser, RA Hayashi, H Heller, GL Hobson, D Hochschorner, G Hortnagel, H Horowski, R Howse, DC Huang, CC Huk, II Hurtig, H Hutton, JT Jaffe, ME Jankovic, J Jardine, M Jog, M Johnson, B Kagamihara, Y Karagoz, N Kasper, S Kato, S Kebabian, JW Kertsz, A Khadilkar, SV Kirk, A Kish, S Kitaguchi, T Kofman, OS Koide, R Komori, T Kostyuk, PG Kumar, R Kuo, HC Kurlan, R Kurland, L Kurtuncu, M Lalkaka, JA Lambert, M Landau, W Lang, AE Lassmann, H Lee, CS Lees, AJ Lieberman, A Litvan, I Loeb, C Logan, WJ Lozano, AM Lu, CS Lucy, D Lynch, T Manyam, BV Maraganore, D Marshall, FT Martin, WRW Martin, WE Mathias, C Matsubera, S Mendis, T Menkes, JH Metz, LN Miyazaki, Y Mizuno, Y Mohr, E Moodley, LG Moore, R Morris, JL Muthane, U Nagaraja, D Nair, CPV Narabayashi, H Nomura, Y Norris, JW Obeso, JA O'Brien, C Oertel, W Ohtake, T Okiyama, R Ozdemir, C Pal, PK Panisset, M Paty, DW Paulson, GW Perlmutter, J Pfeiffer, RF Pifl, C Pincus, JH Poewe, W Quinn, N Rajput, AH Rajput, A Ransmayr, G Rascol, O Robinson, R Rocca, WA Roos, RAC Rosenfeld, MR Russell, D Ruth, TJ Ryu, SJ Sachdev, H Safoschnik, G Sahin, H Sanchez-Ramos, J Satishchandra, P Schapira, A",Scheltens,"Schmidley, JW Schnaberth, G Schneider, E Schneider, JS Schutz, W Seeberger, LC Segawa, M Sethi, KD Shah, A Shannon, K Shelton, P Shihabuddin, B Shimizu, T Shinotoh, H Siddique, T Siderowf, A Sieghart, W Simard, A Simmonds, DC Singhal, BS Sluga, E Snow, BJ Soukop, W Sperk, G Spieker, S Steele, JC Stewart, S Stoessl, AJ Subramony, SH Sundaram, M Sung, CY Surya, N Sweet, RD Tabbal, SD Takahashi, H Taniguchi, M Tarsy, D Teravainen, H Tetrud, JW Tolosa, E Tourtellotte, WW Troupin, AS Tsui, JKC Tuite, P Uc, EY Ueki, Y Uitti, R Uyu, C van Hilten, JJ Veerendrakumar, M Veloso, F Viallet, F Voll, C Vrooman, M Wang, X Ward, I Ward, A Waters, C Weng, YH Wenning, GK Williams, BJ Wilson, TW Wolters, EC Wooten, FG Wszolek, Z Yahr, MD Yanagisawa, N Yokochi, F Young, RR Yu, CM Zifko, U
Citation: G. Abbruzzese et al., An open letter to the Committee on the Nobel Prize in Medicine, PARKINS R D, 7(2), 2001, pp. 149-155
Transdermal dopaminergic D-2 receptor agonist therapy in parkinson's disease with n-0923 TDS: A double-blind, placebo-controlled study
Authors: Hutton, JT Metman, LV Chase, TN Juncos, JL Koller, WC Pahwa, R LeWitt, PA Samii, A Tsui, JKC Calne, DB Waters, CH Calabrese, VP Bennett, JP Barrett, R Morris, JL
Citation: Jt. Hutton et al., Transdermal dopaminergic D-2 receptor agonist therapy in parkinson's disease with n-0923 TDS: A double-blind, placebo-controlled study, MOVEMENT D, 16(3), 2001, pp. 459-463
Preventing falls
Authors: Toto, PE Hutton, JT
Citation: Pe. Toto et Jt. Hutton, Preventing falls, AM J OCCU T, 55(3), 2001, pp. 354-356
A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for Parkinsonian off-state events
Authors: Dewey, RB Hutton, JT LeWitt, PA Factor, SA
Citation: Rb. Dewey et al., A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for Parkinsonian off-state events, ARCH NEUROL, 58(9), 2001, pp. 1385-1392
Levodopa-treated Parkinsons disease has better long-term outcome than previously predicted
Authors: Hutton, JT Tolosa, ES Capildeo, R Morris, JL
Citation: Jt. Hutton et al., Levodopa-treated Parkinsons disease has better long-term outcome than previously predicted, ARCH NEUROL, 57(5), 2000, pp. 758-759
Visual contrast sensitivity in Parkinson's disease is worsened with cabergoline treatment
Authors: Hutton, JT Morris, JL Elias, JW
Citation: Jt. Hutton et al., Visual contrast sensitivity in Parkinson's disease is worsened with cabergoline treatment, PARKINS R D, 5(3), 1999, pp. 87-91
Immediate-release and controlled-release carbidopa/levodopa in PD - A 5-year randomized multicenter study
Authors: Koller, WC Hutton, JT Tolosa, E Capilldeo, R
Citation: Wc. Koller et al., Immediate-release and controlled-release carbidopa/levodopa in PD - A 5-year randomized multicenter study, NEUROLOGY, 53(5), 1999, pp. 1012-1019
Risultati: 1-7 |